These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7868960)

  • 61. Leprosy and the community: the World Health Organisation and leprosy.
    Lepr Rev; 1976 Jun; 47(2):145-53. PubMed ID: 948219
    [No Abstract]   [Full Text] [Related]  

  • 62. Priorities for the future and prospects for leprosy control.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):82-101. PubMed ID: 8326185
    [No Abstract]   [Full Text] [Related]  

  • 63. Potential role of dermatologists and dermatological services in developing and sustaining the leprosy control referral system in resource constrained settings.
    Kawuma HJ
    Lepr Rev; 2007 Mar; 78(1):34-7. PubMed ID: 17518086
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prospects for sustaining leprosy control in Uganda.
    Kawuma HJ
    Lepr Rev; 2010 Dec; 81(4):336-9. PubMed ID: 21313979
    [No Abstract]   [Full Text] [Related]  

  • 65. Integrated framework for action. National Action Plan for Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan.
    J Pak Med Assoc; 2004 Dec; 54(12 Suppl 3):S85-91. PubMed ID: 15745330
    [No Abstract]   [Full Text] [Related]  

  • 66. WHO regional strategy for sustaining leprosy services and further reducing the burden of leprosy, 2006-2010.
    WHO Regional Office for South-East Asia
    Indian J Lepr; 2006; 78(1):33-47. PubMed ID: 16646282
    [No Abstract]   [Full Text] [Related]  

  • 67. Progress towards the elimination of leprosy in Nigeria: a review of the role of policy implementation and operational factors.
    Ogbeiwi OI
    Lepr Rev; 2005 Mar; 76(1):65-76. PubMed ID: 15881037
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Leprosy situation in endemic states of India and prospects of elimination of the disease.
    Subramanian M; Showkath Ali MK; Thorat DM; Muthukumar M; Sathiskumar E; Ramadoss C; Ali Khan M
    Indian J Lepr; 2003; 75(4):335-45. PubMed ID: 15242272
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A three year leprosy control programme in Tamil Nadu (India).
    Malchow-Moller A
    Dan Med Bull; 1974 Oct; 21(6):256. PubMed ID: 4430192
    [No Abstract]   [Full Text] [Related]  

  • 70. [Symposium: How can we contribute to the world leprosy control?].
    Hatano K
    Nihon Hansenbyo Gakkai Zasshi; 2011 Apr; 80(2):137. PubMed ID: 21520585
    [No Abstract]   [Full Text] [Related]  

  • 71. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions.
    Moet FJ; Meima A; Oskam L; Richardus JH
    Lepr Rev; 2004 Dec; 75(4):310-26. PubMed ID: 15682969
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Urban leprosy control--methods used by the German Leprosy Relief Association.
    Mani RS; Devadas TJ
    Indian J Lepr; 1985; 57(3):680-3. PubMed ID: 3831108
    [No Abstract]   [Full Text] [Related]  

  • 73. The decentralization of the health system in Colombia and Brazil and its impact on leprosy control.
    Kalk A; Fleischer K
    Lepr Rev; 2004 Mar; 75(1):67-78. PubMed ID: 15072128
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of dermatologist in post-leprosy elimination era.
    Athreya SP
    Lepr Rev; 2007 Mar; 78(1):40. PubMed ID: 17518088
    [No Abstract]   [Full Text] [Related]  

  • 75. [Present leprosy situation in the world in 2007].
    Suzuki K; Nagaoka Y; Mori S; Ishii N
    Nihon Hansenbyo Gakkai Zasshi; 2008 Feb; 77(1):15-23. PubMed ID: 18341019
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impact of integration of NLEP into PHC system in Madurai district, Tamil Nadu, and status of integration of leprosy patients into the community.
    Elango S
    Indian J Lepr; 2003; 75(4):347-54. PubMed ID: 15242273
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Leprosy elimination campaigns.
    Wkly Epidemiol Rec; 2000 Nov; 75(45):361-6. PubMed ID: 11103150
    [No Abstract]   [Full Text] [Related]  

  • 78. Regarding Brasil, et al.'s adverse effects in leprosy's WHO/MDT and paramedic's role in leprosy control program.
    Cunha Mda G; Schettini AP; Pereira ES; Pedrosa VL; Cruz RC; Sadahiro M
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):257-9. PubMed ID: 9251600
    [No Abstract]   [Full Text] [Related]  

  • 79. [Challenges and proposals for leprosy control in a decentralized health system].
    de Andrade AR
    Rev Soc Bras Med Trop; 2006; 39 Suppl 3():80-2. PubMed ID: 17605215
    [No Abstract]   [Full Text] [Related]  

  • 80. Role of dermatologists in leprosy elimination and in the post-elimination era.
    Trindade MA; Manini MI; Lastória JC
    Lepr Rev; 2007 Mar; 78(1):50-1. PubMed ID: 17518093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.